| 0 | ℹ |
Osimertinib With or Without Chemotherapy in Advanced Non-Small Cell Lung Cancer With EGFR and Concurrent TP53 Mutations: A Randomized Clinical Trial.
(jamanetwork.com)
|
JAMA 2026-08-10 | #nsclc #egfr #chemotherapy #oncology #immunotherapy | |
| 0 | ℹ |
Clinical utility of molecular residual disease detection in early-stage resected EGFR-mutated non-small cell lung cancer.
(nature.com)
|
Nature Communications 2026-08-10 | #nsclc #ctdna #mrd #biomarker #prognosis |